Antonio Fernández‐Serra

Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors

B. Llombart, Carlos Monteagudo, Onofre Sanmartín et al. · Journal of the American Academy of Dermatology · 2011 · 135 citations

Medicine, Oncology, Pathology +16

Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy

Irene Casanova‐Salas, J. Rubio‐Briones, Ana Calatrava et al. · The Journal of Urology · 2014 · 125 citations

Medicine, Molecular Biology, Oncology +17

Molecular diagnosis of dermatofibrosarcoma protuberans: A comparison between reverse transcriptase‐polymerase chain reaction and fluorescence in situ hybridization methodologies

Rocío Salgado, B. Llombart, Ramón M. Pujol et al. · Genes Chromosomes and Cancer · 2011 · 97 citations

Medicine, Molecular Genetics, Pathology +13

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Josefina Cruz, Nicolas Penel et al. · The Lancet Oncology · 2020 · 90 citations

Medicine, Oncology, Pharmacotherapy +2

A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole

Zaida García‐Casado, Ángel Guerrero‐Zotano, Antonio Llombart‐Cussac et al. · BMC Cancer · 2010 · 72 citations · Full text

Medicine, Genetics, Oncology +13